FDG PET/CT imaging evaluates dual combined therapy targeting EMMPRIN and DR5 for pancreatic cancer

被引：0
|
作者：
Kim, Hyunki [1 ]
Zhai, Guihua [1 ]
Samuel, Sharon [1 ]
Rigell, Christopher [1 ]
Umphrey, Heidi [1 ]
Stockard, Cecil [1 ]
Fineberg, Naomi [1 ]
Zinn, Kurt [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
2
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Utility of 18F-FDG PET/CT for Differentiation of Autoimmune Pancreatitis With Atypical Pancreatic Imaging Findings From Pancreatic Cancer
    Lee, Tae Yoon
    Kim, Myung-Hwan
    Park, Do Hyun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Jae Seung
    Lee, Kyu Taek
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (02) : 343 - 348
  • [42] Comparison of 18F-FDG PET/CT imaging with different dual time 18F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer
    Yu, Longhua
    Huang, Shiming
    Wu, Siyu
    Yue, Jianlan
    Yin, Liang
    Lin, Zhichun
    MEDICINE, 2023, 102 (02) : E32331
  • [43] Dual energy CT attenuation correction methods for quantitative assessment of response to cancer therapy with PET/CT imaging
    Kinahan, Paul E.
    Alessio, Adam M.
    Fessler, Jeffrey A.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2006, 5 (04) : 319 - 327
  • [44] Contrast enhanced FDG-PET/CT-"one stop shop" imaging for pancreatic cancer resectability assessment
    Strobel, K.
    Schaefer, M.
    Veit-Haibach, P.
    Pestalozzi, B.
    Seifert, B.
    Clavien, P.
    Hany, T. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S162 - S163
  • [45] FDG PET/CT as imaging biomarker in the era of molecular targeting therapies: sequential FDG PET/CT demonstrated biological response and acquisition of resistance to tyrosine kinase inhibitor therapy for renal cell carcinoma
    Nakaigawa, N.
    Namura, K.
    Ueno, D.
    Tateishi, U.
    Inoue, T.
    Yao, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 154 - 154
  • [46] Editorial Comment: FDG PET/MRI and CT as Predictive Markers of Response of Borderline Resectable Pancreatic Cancer to Neoadjuvant Therapy
    Lee, Jean H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (03) : 740 - 740
  • [47] Dual phase 18F-FDG PET/CT imaging in evaluation of "radio-recurrent" prostate cancer
    Haroon, Athar
    Almuhaideb, Ahmad
    Dickson, John
    Ahmed, Hashim
    Syed, Rizwan
    Kirkham, Alex
    Kayani, Irfan
    Emberton, Mark
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [48] COMBINED 18F-FDG-PET/CT IMAGING IN RADIOTHERAPY TARGET DELINEATION FOR HEAD-AND-NECK CANCER
    Guido, Alessandra
    Fuccio, Lorenzo
    Rombi, Barbara
    Castellucci, Paolo
    Cecconi, Agnese
    Bunkheila, Feisal
    Fuccio, Chlara
    Spezi, Emiliano
    Angelini, Anna Lisa
    Barbieri, Enza
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03): : 759 - 763
  • [49] Combined morphological and functional imaging with FDG-PET/CT for restaging breast cancer - Impact on patient management.
    Buck, AK
    Wahl, A
    Eicher, U
    Blumstein, N
    Schirrmeister, H
    Helms, G
    Glatting, G
    Neumaier, B
    Reske, SN
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 78P - 78P
  • [50] Dual-phase 18F-FDG PET/CT imaging in the characterization of pancreatic lesions: does it offer prognostic information?
    Santhosh, Sampath
    Mittal, Bhagwant R.
    Bhasin, Deepak
    Rana, Surinder S.
    Bhattacharya, Anish
    Srinivasan, Radhika
    Nada, Ritambhra
    Gupta, Rajesh
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (10) : 1018 - 1025
12345